These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

639 related items for PubMed ID: 34014450

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in non-alcoholic fatty liver disease.
    Dongiovanni P, Meroni M, Baselli GA, Bassani GA, Rametta R, Pietrelli A, Maggioni M, Facciotti F, Trunzo V, Badiali S, Fargion S, Gatti S, Valenti L.
    Clin Sci (Lond); 2017 Jun 01; 131(12):1301-1315. PubMed ID: 28468951
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Selective depletion of hepatic stellate cells-specific LOXL1 alleviates liver fibrosis.
    Yang A, Yan X, Xu H, Fan X, Zhang M, Huang T, Li W, Chen W, Jia J, You H.
    FASEB J; 2021 Oct 01; 35(10):e21918. PubMed ID: 34569648
    [Abstract] [Full Text] [Related]

  • 5. Role of XBP1 in regulating the progression of non-alcoholic steatohepatitis.
    Wang Q, Zhou H, Bu Q, Wei S, Li L, Zhou J, Zhou S, Su W, Liu M, Liu Z, Wang M, Lu L.
    J Hepatol; 2022 Aug 01; 77(2):312-325. PubMed ID: 35292349
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Thrombospondin-I is a critical modulator in non-alcoholic steatohepatitis (NASH).
    Min-DeBartolo J, Schlerman F, Akare S, Wang J, McMahon J, Zhan Y, Syed J, He W, Zhang B, Martinez RV.
    PLoS One; 2019 Aug 01; 14(12):e0226854. PubMed ID: 31891606
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Investigating fibrosis and inflammation in an ex vivo NASH murine model.
    Gore E, Bigaeva E, Oldenburger A, Jansen YJM, Schuppan D, Boersema M, Rippmann JF, Broermann A, Olinga P.
    Am J Physiol Gastrointest Liver Physiol; 2020 Feb 01; 318(2):G336-G351. PubMed ID: 31905025
    [Abstract] [Full Text] [Related]

  • 10. Lactate transporter MCT1 in hepatic stellate cells promotes fibrotic collagen expression in nonalcoholic steatohepatitis.
    Min K, Yenilmez B, Kelly M, Echeverria D, Elleby M, Lifshitz LM, Raymond N, Tsagkaraki E, Harney SM, DiMarzio C, Wang H, McHugh N, Bramato B, Morrison B, Rothstein JD, Khvorova A, Czech MP.
    Elife; 2024 Apr 02; 12():. PubMed ID: 38564479
    [Abstract] [Full Text] [Related]

  • 11. Analysis of the Role of Stellate Cell VCAM-1 in NASH Models in Mice.
    Chung KJ, Legaki AI, Papadopoulos G, Gercken B, Gebler J, Schwabe RF, Chavakis T, Chatzigeorgiou A.
    Int J Mol Sci; 2023 Mar 02; 24(5):. PubMed ID: 36902241
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Imaging Fibrogenesis in a Diet-Induced Model of Nonalcoholic Steatohepatitis (NASH).
    Hartimath SV, Boominathan R, Soh V, Cheng P, Deng X, Chong YC, Yong FF, Tan PW, Han W, Robins EG, Goggi JL.
    Contrast Media Mol Imaging; 2019 Mar 02; 2019():6298128. PubMed ID: 31866798
    [Abstract] [Full Text] [Related]

  • 15. Regulation of the macrophage-hepatic stellate cell interaction by targeting macrophage peroxisome proliferator-activated receptor gamma to prevent non-alcoholic steatohepatitis progression in mice.
    Ni XX, Ji PX, Chen YX, Li XY, Sheng L, Lian M, Guo CJ, Hua J.
    Liver Int; 2022 Dec 02; 42(12):2696-2712. PubMed ID: 36165186
    [Abstract] [Full Text] [Related]

  • 16. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis.
    Witek RP, Stone WC, Karaca FG, Syn WK, Pereira TA, Agboola KM, Omenetti A, Jung Y, Teaberry V, Choi SS, Guy CD, Pollard J, Charlton P, Diehl AM.
    Hepatology; 2009 Nov 02; 50(5):1421-30. PubMed ID: 19676126
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Transgenic expression of human neutrophil peptide-1 enhances hepatic fibrosis in mice fed a choline-deficient, L-amino acid-defined diet.
    Ibusuki R, Uto H, Arima S, Mawatari S, Setoguchi Y, Iwashita Y, Hashimoto S, Maeda T, Tanoue S, Kanmura S, Oketani M, Ido A, Tsubouchi H.
    Liver Int; 2013 Nov 02; 33(10):1549-56. PubMed ID: 23682724
    [Abstract] [Full Text] [Related]

  • 19. Role of CC chemokine receptor 9 in the progression of murine and human non-alcoholic steatohepatitis.
    Morikawa R, Nakamoto N, Amiya T, Chu PS, Koda Y, Teratani T, Suzuki T, Kurebayashi Y, Ueno A, Taniki N, Miyamoto K, Yamaguchi A, Shiba S, Katayama T, Yoshida K, Takada Y, Ishihara R, Ebinuma H, Sakamoto M, Kanai T.
    J Hepatol; 2021 Mar 02; 74(3):511-521. PubMed ID: 33038434
    [Abstract] [Full Text] [Related]

  • 20. Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis.
    Widjaja AA, Singh BK, Adami E, Viswanathan S, Dong J, D'Agostino GA, Ng B, Lim WW, Tan J, Paleja BS, Tripathi M, Lim SY, Shekeran SG, Chothani SP, Rabes A, Sombetzki M, Bruinstroop E, Min LP, Sinha RA, Albani S, Yen PM, Schafer S, Cook SA.
    Gastroenterology; 2019 Sep 02; 157(3):777-792.e14. PubMed ID: 31078624
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.